Single vs. Double Drain in Modified Radical Mastectomy

April 2, 2015 updated by: salma khan, Memon Medical Institute

Single vs. Double Drain in Modified Radical Mastectomy: A Randomized Control Trial

Seroma is a common complication following modified radical mastectomy(MRM). Closed drainage is used routinely to reduce incidence of seroma. Usually two drains are used in patients who underwent MRM to reduce post operative seroma. It is often associated with significant patient discomfort and prolonged fluid drainage.

The aim of this study is to evaluate effect of number of drains on seroma formation rate, postoperative pain and hospital stay during the immediate postoperative period after mastectomy for breast cancer.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Modified Radical mastectomy is commonly performed procedure for carcinoma breast. After surgery two drains are placed, one in axilla and one beneath the flap. The use of two drains is associated with significant post operative discomfort and pain. On the other hand two drains have not been proven to decrease post operative seroma formation.

Study Type

Interventional

Enrollment (Actual)

176

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • All female patients underwent MRM for biopsy proven carcinoma breast

Exclusion Criteria:

  • Immediate reconstruction
  • Patient refusal to participate in study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Single drain in modified radical mastectomy
Post modified radical mastectomy with either one or two drains Intervention is use of single or double drain
Post modified radical mastectomy with either one or two drains Intervention is use of single or double drain
Active Comparator: Double drain in modified radical mastectomy
Post modified radical mastectomy with either one or two drains Intervention is use of single or double drain
Post modified radical mastectomy with either one or two drains Intervention is use of single or double drain

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
seroma formation
Time Frame: 30 days post surgery
fluid collection beneath the flap sufficient to cause patient discomfort and pain
30 days post surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration of hospital stay,,
Time Frame: 30 days after surgery
30 days after surgery
wound infection
Time Frame: 30 days after surgery
as described by center of disease control (CDC) criteria
30 days after surgery
postoperative pain
Time Frame: 30 days after surgery
measured on visual analogue scale (1 to 10) in first 24 hours after surgery.
30 days after surgery
hematoma
Time Frame: 30 days after surgery
blood collection under the flap
30 days after surgery
flap necrosis
Time Frame: 30 days after surgery
flap discoloration due to compromised blood supply of flap
30 days after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (Actual)

November 1, 2014

Study Completion (Actual)

November 1, 2014

Study Registration Dates

First Submitted

February 27, 2015

First Submitted That Met QC Criteria

April 2, 2015

First Posted (Estimate)

April 8, 2015

Study Record Updates

Last Update Posted (Estimate)

April 8, 2015

Last Update Submitted That Met QC Criteria

April 2, 2015

Last Verified

April 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • ERC:02

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Cancer

Clinical Trials on Drain

3
Subscribe